Inactive Instrument

Calendar Santhera Pharmaceuticals Holding AG Xetra

Equities

S3F

CH0027148649

Chart calendar Santhera Pharmaceuticals Holding AG

455e450ad63ef14cb1015c36.l8-QA0o-QZpHIPdCcTkgFEgIbcXxDdXvunaWEGqmVjs.xOLEaiR9A_5zDZY3I09rcz86OJ3Ga6eW4jH_aC_WNUqvt_c1K3MsznJmgA~188e9a00ade5d64203a6bc9f919de8db

Upcoming events on Santhera Pharmaceuticals Holding AG

18/06/2024 01:30 pm Annual General Meeting
04/09/2024 Q2 2024 Earnings Release (Projected)
24/04/2025 Q4 2024 Earnings Release (Projected)
03/09/2025 Q2 2025 Earnings Release (Projected)
23/04/2026 Q4 2025 Earnings Release (Projected)

Past events on Santhera Pharmaceuticals Holding AG

25/04/2024 06:00 pm Q4 2023 Earnings Call
25/04/2024 10:30 am Q4 2023 Earnings Release
03/10/2023 World Muscle Society Congress
12/09/2023 07:30 pm H.C. Wainwright Global Investment Conference
07/09/2023 06:00 pm Q2 2023 Earnings Call
07/09/2023 10:30 am Q2 2023 Earnings Release
03/07/2023 Reverse Split: 1 of 10
29/06/2023 PPMD Conference
27/06/2023 01:30 pm Annual General Meeting
27/04/2023 06:00 pm Q4 2022 Earnings Call
27/04/2023 10:30 am Q4 2022 Earnings Release
19/03/2023 MDA Clinical & Scientific Conference
29/11/2022 03:00 pm Extraordinary Shareholders Meeting
07/11/2022 07:00 pm Interim 2022 Earnings Call
31/10/2022 11:30 am Interim 2022 Earnings Release
14/10/2022 11:10 pm World Muscle Society Congress - Poster : #FP.27
14/10/2022 11:00 pm World Muscle Society Congress - Poster : #P.133
13/10/2022 12:30 am World Muscle Society Congress - Poster : #P.71
12/10/2022 11:10 pm World Muscle Society Congress - Poster : #FP.03
30/06/2022 02:00 pm Annual General Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million CHF
Released
Forecast
Spread
75,4
76,1
-0.95%
15,0
15,0
0.05%
-1,60
8,00
-119.94%
7,47
0,00
-
103
8,29
1147%

51,1

EBITDA
Million CHF
Released
Forecast
Spread
-5,67
-1,92
-195.13%
-45,9
-42,0
-9.38%
-39,6
-25,0
-58.26%
-42,1
-35,0
-20.34%
0,00
0,00
-

-27,0

EBIT
Million CHF
Released
Forecast
Spread
-10,4
-5,30
-97.19%
-53,1
-51,5
-3.06%
-56,9
-29,0
-96.17%
-52,0
-39,0
-33.27%
68,8
-48,0
243.32%

-30,0

Earnings before Tax (EBT)
Million CHF
Released
Forecast
Spread
-18,4
0,41
-4597.31%
-67,5
-62,5
-7.93%
-54,7
-39,0
-40.3%
-69,7
-47,0
-48.27%
0,00
0,00
-

-35,0

Net income
Million CHF
Released
Forecast
Spread
-19,0
0,41
-4738.88%
-67,7
-71,0
4.71%
-55,5
-39,0
-42.37%
-70,1
-47,0
-49.25%
0,00
0,00
-

-35,0

EPS
CHF
Released
Forecast
Spread
-17,3
0,37
-4775.68%
-50,8
-42,3
-20.09%
-16,2
-7,20
-125%
-11,7
-6,30
-85.71%
0,00
0,00
-

-2,81

Announcement Date24/03/2029/04/2110/06/2227/04/2325/04/24-

Quarterly results

Fiscal PeriodDecember 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million CHF
Released
Forecast
Spread

1,85


1,99


2,05


2,40


5,70


10,3


13,7


21,4

EBIT
Million CHF
Released
Forecast
Spread

-10,5


-11,5


-12,6


-13,5













Announcement Date--------
  1. Stock Market
  2. Equities
  3. SANN Stock
  4. S3F Stock
  5. Calendar Santhera Pharmaceuticals Holding AG